Publications describing the use of

The Dermatitis Family Impact Questionnaire

1.      Lawson V, Lewis-Jones M S, Finlay A Y, Reid P, Owens RG.  The family impact of childhood atopic dermatitis:  the Dermatitis Family Impact questionnaire.  Br J Dermatol 1998; 138: 107-113.

2.      Lewis-Jones MS, Finlay AY, Dykes PJ.  Measurement of the impact of atopic dermatitis on infant’s and their families lives.  British Journal of Dermatology 1999; 141 (Suppl 55): 105-106.

3.      Foo C, Schofield OM.  Influences on the quality of family life in atopic eczema.  British Journal of Dermatology 2000; 143 (Suppl 5): 45.

4.      Ben-Gashir M A, Seed P T, Hay R J.  Are quality of family life and disease severity related in childhood atopic dermatitis?  JEADV 2002; 16: 455-462.

5.      Aziah M S, Rosnah T, Mardziah A, Norzila M Z.  Childhood atopic dermatitis:  a measurement of quality of life and family impact.  Med J Malaysia  2002; 57:  329-39.

6.      Balkrishanan R, Housman T S, Grummer S, Rapp S R, Jan Clarke R N, Steven R, Feldman M D, Fleischer A B.  The family impact of atopic dermatitis in children:  The role of the parent caregiver.  Ped Dermatol 2003; 20(1): 5-10.

7.      Humbert Ph, Basses-Bresca S, van der Valk P, Mengeaud V, Ermosilla V, Boyer F, Merot F.  Interest of an emollient combination of two hygiene products and a cream containing Oak Rhealba ® extract in atopic dermatitis.  JEADV 2003; 17 (Suppl 3): 174.

8.      Beattie P E, Lewis-Jones M S.  A pilot study on the use of wet wraps in infants with moderate atopic eczema.  Clin Exp Dermatol 2004; 29(4): 348-353.

9.      Taďeb C, Macy G, Sibaud V, Myon E.  Atopic dermatitis:  European evaluation in young children.  JEADV 2004; 18 (Suppl 2) 300.

10.  Weber M, Mazzotti N, Barzenski B, Silva T.  Evaluation of the quality of life in patients with atopic dermatitis participating in support groups.  J Am Acad Dermatol 2005; 52 (Suppl 1): 70.

11.  Beattie P E, Lewis-Jones M S.  An audit of the usefulness of quality of life measures in secondary care for assessing the impact of atopic dermatitis on infants and their families and the benefit obtained from consultation with a dermatology team.  BJD 2005; 153 (Suppl 1): 82.

12.  Baron S E, Layton A, Goulden V.  A pilot study of hypnotherapy to treat adults and children with moderate to severe atopic dermatitis.  BJD 2005; 153 (Suppl 1): 37.

13.  Beattie P E, Lewis-Jones M S.  An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families:  further validation of the Infants’ Dermatitis Quality of Life Index and Dermatitis Family Impact Score.  .  BJD 2006; 155: 1249-1255.

14.  Msika P.  New natural PPAR-a agonist for childhood atopic dermatitis:  Dermocorti-coid-sparing and quality of life improvement.  J am Acad Dermatol 2007; February AB67.

15.  Ganemo A, Svensson A, Lindberg M, Wahlgren C-F.  Quality of life in Swedish children with eczema.  Acta Derm Venereol 2007; 87:345-349.

16.  de Belilovsky C, Chdoutaud B, Msika P.  Cosmetics and quality of life.  JEADV 2007;